Brasartan CTDN® - GrupoFarma Ecuador

https://en.grupofarmadelecuador.com/wp-content/uploads/2021/06/GrupoFarma-Ecuador-Producto-Cardiovascular-Brasartan-1-320x73.png
GrupoFarma-Ecuador-Producto-Cardiovascular-Brasartan-2-80mg
GrupoFarma-Ecuador-Producto-Cardiovascular-Brasartan-3-80mg
GrupoFarma-Ecuador-Producto-Cardiovascular-Brasartan-4-160mg

Composition
Each tablet contains Valsartan / Chlorthalidone.

Presentation

  • 80 mg Valsartan / 12.5 mg Chlorthalidone – Box X 30 Tablets
  • 80 mg Valsartan / 25 mg Chlorthalidone – Box X 30 Tablets
  • 160 mg Valsartan / 25 mg Chlorthalidone – Box X 30 Tablets

Indications
Treatment of mild to moderate arterial hypertension. Treatment of heart failure stages II to IV.

Sale under prescription.

Other products

https://en.grupofarmadelecuador.com/wp-content/uploads/2021/07/Grupo-Farma-del-Ecuador.png
https://en.grupofarmadelecuador.com/wp-content/uploads/2021/07/Grupo-Farma-del-Ecuador.png
https://en.grupofarmadelecuador.com/wp-content/uploads/2021/07/Grupo-Farma-del-Ecuador-Footer.png

¡Accompanying you and your health!
We improve the level in the health of our community, through advanced medicines, own or internationally licensed.

Subscribe

Text text.

[contact-form-7 404 "Not Found"]
Applauz

As the pioneer of the lean startup movement, APPLAUZ has dedicated it’s time to sharing effective business strategies that help new businesses and enterpreneurs put their money to work in the right way.

The information provided on this website was prepared by GrupoFarma S.A. and directed exclusively to medical personnel and health professionals. It may NOT be considered general use for people, nor as medical advice, recommendations or medical advice of any kind. We suggest not to self-medicate and consult your doctor beforehand about any concerns related to the information on the products or drugs mentioned here. Laboratories Farma S.A. will not be responsible for the misuse that third parties may give to the information obtained here.